Sublingual methadone

DRUG4 trials

Sponsors

Alberta Cancer Board (Canada), Alberta Health services, AHS Cancer Control Alberta

Conditions

CancerCancer-related breakthrough pain Cancer Pain, cancerPain

Phase 2

Sublingual methadone for the management of cancer-related procedural pain in inpatients

Active, not recruitingISRCTN72738824

Alberta Cancer Board (Canada)Cancer-related breakthrough pain Cancer Pain, cancer

Start: 2006-06-01Target: 20Updated: 2019-02-11

Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients

TerminatedNCT00351637

Alberta Health servicesCancer, Pain

Start: 2006-12-31End: 2008-09-30Target: 60Updated: 2012-01-19

Sublingual Methadone for the Management of Cancer-related Breakthrough Pain in Outpatients

TerminatedNCT00351715

AHS Cancer Control AlbertaCancer, Pain

Start: 2008-07-31End: 2008-09-30Updated: 2019-10-21

Unknown Phase

Sublingual methadone for the management of cancer-related breakthrough pain in outpatients

Active, not recruitingISRCTN61713542

Alberta Cancer Board (Canada)Cancer-related breakthrough pain Cancer Pain, cancer

Start: 2006-06-01Target: 42Updated: 2019-02-11